This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Newsome, S. D. Articles by Castaneda, G. Y. Search for Related Content PubMed PubMed Citation Articles by Newsome, S. D. Articles by Castaneda, G. Y. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Social Bookmarking                         What's this?

Levetiracetam-Induced Diffuse Interstitial Lung Disease

Department of Neurology, Albany Medical Center, Albany, NY, newsoms{at}mail.amc.edu

Lanny Y. Xue, MD, PhD

Department of Neurology, Albany Medical Center, Albany, NY

Timothy Jennings, MD

Department of Pathology Albany Medical Center, Albany, New York.

Glenn Y. Castaneda, MD

Department of Neurology, Albany Medical Center, Albany, NY

The authors report the first case of levetiracetam-induced diffuse interstitial lung disease. The patient is a 9-year-old girl who was admitted to the pediatric intensive care unit for aspiration pneumonia. She has a history of epilepsy, cerebral palsy, mental retardation, asthma, and repeated hospitalizations for presumed aspiration pneumonia, which resolved with conventional medical treatment. She has been on low-dose levetiracetam for her epilepsy over the past 2 years, and the dosage was increased just prior to this admission. However, this time, with conventional treatment, the patient's aspiration pneumonia did not improve, which led to a lung biopsy. The biopsy demonstrated a diffuse interstitial process of relatively recent onset, with features consistent with diffuse lung disease. Levetiracetam was implicated in the pathogenesis of the interstitial pneumonitis. The patient improved clinically after the discontinuation of levetiracetam and with the treatment of steroids.

Key Words: levetiracetam • diffuse lung disease • pneumonitis • pneumonia • interstitial lung disease • antiepileptic drug

Journal of Child Neurology, Vol. 22, No. 5, 628-630 (2007)
DOI: 10.1177/0883073807302602


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?